Table 2.
Patient Characteristics
| Variable | LR Group (n = 24) | NS Group (n = 26) |
|---|---|---|
| Age (years) | ||
| Median (IQR) | 3.8 (2.0–10.4) | 9.7 (2.6–16.3) |
| 6 months to <1 year | 1 (4) | 2 (8) |
| 1 to <6 years | 14 (58) | 8 (31) |
| 6 to <13 years | 5 (21) | 7 (27) |
| 13 to 17 years | 4 (17) | 9 (35) |
| Sex | ||
| Female | 11 (46) | 12 (46) |
| Race/ethnicity | ||
| Non-Hispanic white | 11 (46) | 11 (42) |
| Non-Hispanic black | 3 (13) | 4 (15) |
| Hispanic | 10 (42) | 9 (35) |
| Asian | 0 (0) | 1 (4) |
| Unknown/not reported | 0 (0) | 1 (4) |
| Comorbid conditions | ||
| Cancer | 4 (17) | 5 (19) |
| Kidney disease (no dialysis) | 2 (8) | 1 (4) |
| Neurologic dysfunction | 7 (29) | 5 (19) |
| Chronic ventilator dependence | 6 (25) | 5 (19) |
| Bone marrow or solid organ transplant | 3 (13) | 2 (8) |
| Sickle cell disease | 0 (0) | 2 (8) |
| Indwelling central venous catheter | 6 (25) | 4 (15) |
| Any comorbid condition | 16 (67) | 16 (62) |
| Site of infection | ||
| Bacteremia | 2 (8) | 4 (15) |
| Pneumonia/lung infection | 5 (21) | 5 (19) |
| Abdominal infection | 1 (4) | 0 (0) |
| Urinary tract infection | 4 (17) | 3 (12) |
| CNS infection | 2 (8) | 3 (12) |
| Skin/soft tissue infection | 2 (8) | 3 (12) |
| Other | 6 (25) | 6 (23) |
| Unknown | 3 (13) | 4 (15) |
| Alternative diagnosis other than infection | 1 (4) | 1 (4) |
| Enrollment method | ||
| EFIC | 22 (92) | 22 (85) |
CNS = central nervous system; EFIC = exception from informed consent; IQR = interquartile range.
Categorical data are presented as n (%); continuous data are presented as median (IQR)